RJ, G., SA, L., B, B., B, C., L, L., GM, M., . . . WE, G. (2017). Vascular Imaging of Matrix Metalloproteinase Activity as an Informative Preclinical Biomarker of Drug-induced Vascular Injury. Toxicologic pathology, 45(5), 633. https://doi.org/10.1177/0192623317720731
Chicago Style (17th ed.) CitationRJ, Gonzalez, et al. "Vascular Imaging of Matrix Metalloproteinase Activity as an Informative Preclinical Biomarker of Drug-induced Vascular Injury." Toxicologic Pathology 45, no. 5 (2017): 633. https://doi.org/10.1177/0192623317720731.
MLA (9th ed.) CitationRJ, Gonzalez, et al. "Vascular Imaging of Matrix Metalloproteinase Activity as an Informative Preclinical Biomarker of Drug-induced Vascular Injury." Toxicologic Pathology, vol. 45, no. 5, 2017, p. 633, https://doi.org/10.1177/0192623317720731.